
CEPI
@CEPIvaccines
Followers
44K
Following
8K
Media
5K
Statuses
13K
Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission
Global
Joined October 2016
Over 8 million people. That is the number of people who might be alive today if the international community had accomplished the 100 Days Mission to develop safe and effective new vaccines against SARS-CoV-2 in three months. 👉. @imperialcollege
19
16
35
The #100DaysMission's success relies on establishing an enabling regulatory environment. One that can go even faster than the COVID response, whilst maintaining appropriate levels of regulatory oversight. CEPI experts describe how to achieve this ⬇️
linkedin.com
Authored by Adam Hacker, Head of Regulatory Affairs and Quality, CEPI, and Meenu Batolar, Regulatory Affairs Asia Pacific Lead, CEPI In a rural Indian community, a mysterious disease has emerged....
0
1
4
💡Enable 1.5 is a pioneering CEPI-supported study aiming to advance our understanding of Lassa fever virus and help inform Lassa vaccine development efforts. Read the study protocol, now published in @bmj_latest Public Health: 📸@NCDCgov
1
9
22
RT @pandemiccenter: From @Brown_SPH: Biosecurity Game Changer Sana Masmoudi has been in partnership with @CEPIvaccines over the last year a….
sph.brown.edu
As part of Brown’s new Biosecurity Game Changers fellowship, pharmacist and policy expert Sana Masmoudi is working to close critical biosecurity gaps—building systems, shaping policy and mentoring...
0
5
0
CEPI has committed up to US$100 million to advance multiple Chikungunya vaccine candidates, one of which was the first-ever to receive FDA approval. Now, we're working to expand global access to this vaccine 💉. Learn more about #chikungunya ⬇️
cepi.net
CEPI is advancing Chikungunya vaccine candidates through late-stage trials, focusing on expanding access to vulnerable populations in endemic
0
0
0
#Chikungunya is a mosquito-borne disease belonging to the togavirus viral family🦠. It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟
10
3
8
📣 Korea's Disease Control and Prevention Agency and @IVIHeadquarters are joining our Centralised Labs Network, the world's largest group of laboratories working to standardise the assessment of new infectious disease vaccines 🇰🇷.
0
1
3
RT @GHTCoalition: Scientists have launched the first-ever adjuvant library, substances that boost vaccines' ability to create immunity. The….
0
1
0
RT @CEPIvaccines: In late 2024, Marburg virus hit Rwanda for the first time. A new NPJ Vaccines article details how CEPI and partners hel….
link.springer.com
npj Vaccines - How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
0
8
0
For more on the real-world life-saving impact of this and many other aspects of CEPI’s 100 Days Mission readiness work, go to our Impact page and read our Innovations for Impact series.
cepi.net
CEPI supports more than 150 active R&D and manufacturing projects in over 50 countries around the world, building critical capabilities for the 100
0
0
0
In the paper, CEPI’s @DrRHatchett and Dr Nicole Lurie and co-authors from @RwandaHealth, @RBCRwanda, @IQVIA and @sabinvaccine detail the #100DaysMission readiness work that fed into this unprecedented and highly effective response. .
1
0
0
In late 2024, Marburg virus hit Rwanda for the first time. A new NPJ Vaccines article details how CEPI and partners helped to quickly end the outbreak, with a Marburg vaccine deployed in a clinical trial just 10 days after the outbreak was declared ⬇️
link.springer.com
npj Vaccines - How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
2
8
13
📣We’re launching the world's first library of adjuvants that can be ‘taken off the shelf’ and used to develop new epidemic and pandemic vaccines. Hosted by @MHRAgovuk, the $2.5m project will help developers select the best vaccine-adjuvant combinations:
0
6
13